Literature DB >> 3688566

Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium metabisulfite nasal provocation in intolerant rhinitic patients.

C Ortolani1, C Mirone, A Fontana, G C Folco, A Miadonna, N Montalbetti, M Rinaldi, A Sala, A Tedeschi, D Valente.   

Abstract

Nasal histamine (H), leukotriene C4 (I-LTC4) and SRS-A activity were studied in seven aspirin-(ASA)-intolerant patients (AIR) with rhinitis and in five ASA-tolerant control patients with chronic rhinitis after nasal provocation (NP) with a lysine acetylsalicylate solution. The same parameters were also studied after metabisulfite (MBS) NP in four sulfite-intolerant patients with rhinitis and in six control patients with chronic rhinitis. In six ASA-intolerant subjects and in four controls, we studied the PGD2 levels in nasal washes after ASA NP 0.2 mL of lysine acetylsalicylate solution (10 mg/mL) was sprayed intranasally in ASA-intolerant patients and controls and a 25-mg/mL MBS solution in sulfite intolerant patients and controls. Nasal wash fluids were obtained using 5 mL of 0.15 M saline before and 7 1/2, 15, 30, and 60 minutes after nasal provocation. The nasal provocation with ASA induced itching and sneezing in four out of seven intolerant subjects. In this subgroup histamine values in nasal wash fluids were significantly higher versus the remaining ASA-intolerant patients at 30 and 60 minutes (P less than .05 and P less than .01, respectively) and versus controls at 60 minutes (P less than .01). We found significantly higher I-LTC4 (P less than .01) and SRS-A levels in nasal washes collected from ASA-intolerant subjects versus controls at 60 minutes after nasal provocation. There was no significant increase in the mean PGD2 values in either the ASA-intolerant or control groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3688566

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  7 in total

1.  Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma.

Authors:  A r Sousa; R Pfister; P E Christie; S J Lane; S M Nasser; M Schmitz-Schumann; T H Lee
Journal:  Thorax       Date:  1997-11       Impact factor: 9.139

2.  Effect of endobronchial aspirin challenge on inflammatory cells in bronchial biopsy samples from aspirin-sensitive asthmatic subjects.

Authors:  S Nasser; P E Christie; R Pfister; A R Sousa; A Walls; M Schmitz-Schumann; T H Lee
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

Review 3.  Allergy and intolerance to nonsteroidal anti-inflammatory agents.

Authors:  A Arnaud
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

4.  Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.

Authors:  S M Nasser; G S Bell; S Foster; K E Spruce; R MacMillan; A J Williams; T H Lee; J P Arm
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

5.  Bilateral Inflammatory Aural Polyps: A Manifestation of Samter's Triad.

Authors:  Robert Brobst; Nichole Suss; Stephanie Joe; Saadia Redleaf
Journal:  Int J Otolaryngol       Date:  2010-02-21

Review 6.  Nimesulide in the treatment of patients intolerant of aspirin and other NSAIDs.

Authors:  G E Senna; G Passalacqua; G Andri; A R Dama; M Albano; L Fregonese; L Andri
Journal:  Drug Saf       Date:  1996-02       Impact factor: 5.606

Review 7.  Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin.

Authors:  S Bianco; M Robuschi; G Petrigni; M Scuri; M G Pieroni; R M Refini; A Vaghi; P S Sestini
Journal:  Drugs       Date:  1993       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.